(Q34067401)

30 July 2017

1 reference

title

Pharmacoeconomics of influenza vaccination in the elderly: reviewing the available evidence (English)

1 reference

30 July 2017

Postma MJ

1

1 reference

30 July 2017

Baltussen RM

2

1 reference

30 July 2017

Heijnen ML

3

1 reference

30 July 2017

de Berg LT

4

1 reference

30 July 2017

Jager JC

5

1 reference

30 July 2017

publication date

1 September 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

17

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

217-227

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-200017030-00005

30 July 2017

exact match

0 references

cites work

Cost-effectiveness league tables: More harm than good?

1 reference

12 December 2020

The swine-influenza decision

1 reference

12 December 2020

Review of cost-benefit analyses of influenza vaccine

1 reference

12 December 2020

Pharmacists' role in immunization

1 reference

12 December 2020

Economic evaluation of vaccination against influenza in New Zealand.

1 reference

12 December 2020

The health and economic benefits of influenza vaccination for healthy and at-risk persons aged 65 to 74 years

1 reference

12 December 2020

Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people

1 reference

12 December 2020

Discounting and health benefits: another perspective

1 reference

12 December 2020

The impact of age on cost-effectiveness ratios and its control in decision making

1 reference

12 December 2020

Influenza vaccination

1 reference

12 December 2020

Years of potential life lost (YPLL)--what does it measure?

1 reference

12 December 2020

Community pharmacists as immunization advocates. Cost-effectiveness of a cue to influenza vaccination.

1 reference

12 December 2020

An exercise on the feasibility of carrying out secondary economic analyses

1 reference

12 December 2020

Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977

1 reference

12 December 2020

Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness

1 reference

12 December 2020

Vaccination against influenza: a five-year study in the Post Office

1 reference

12 December 2020

Public health burden of vaccine-preventable diseases among adults: standards for adult immunization practice

1 reference

12 December 2020

Disease-staging for modelling current and future health-care impact of disease: illustrations for diabetes mellitus and AIDS.

1 reference

12 December 2020

A perspective on the significance of pandemic influenza

1 reference

12 December 2020

Prevention of respiratory infections in adults. Influenza and pneumococcal vaccines

1 reference

12 December 2020

Real world designs in economic evaluation. Bridging the gap between clinical research and policy-making

1 reference

12 December 2020

Clinical effectiveness of influenza vaccination in Manitoba

1 reference

12 December 2020

Prevention and control of type A influenza infections in nursing homes. Benefits and costs of four approaches using vaccination and amantadine

1 reference

12 December 2020

The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial

1 reference

12 December 2020

The costs and benefits of preventing influenza in Ontario's elderly

1 reference

12 December 2020

Prevention of influenza in the elderly

1 reference

12 December 2020

Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization

1 reference

12 December 2020

Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women

1 reference

12 December 2020

Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly

1 reference

12 December 2020

Is immunising all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice based clinical prospective cohort study in Utrecht, The Netherlands

1 reference

12 December 2020

Leads from the MMWR. Prevention and control of influenza

1 reference

12 December 2020

The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.

1 reference

12 December 2020

Estimates of the US health impact of influenza

1 reference

12 December 2020

Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention

1 reference

12 December 2020

Influenza vaccination in Australia: a review of the economic evidence for policy recommendations.

1 reference

12 December 2020

Willingness to pay and the valuation of programmes for the prevention and control of influenza.

1 reference

12 December 2020

Vaccination and herd immunity to infectious diseases

1 reference

12 December 2020

Evaluating the impact of influenza vaccination. A North American perspective

1 reference

12 December 2020

Estimating influenza-related hospitalization in The Netherlands

1 reference

12 December 2020

Universal HIV screening of pregnant women in England: cost effectiveness analysis

1 reference

12 December 2020

Influenza vaccination in 29 countries. An update to 1997.

1 reference

12 December 2020

How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations

1 reference

12 December 2020

Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons

1 reference

12 December 2020

Discounting and health benefits

1 reference

12 December 2020

Interpretation of cost-effectiveness analyses

1 reference

12 December 2020

Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic

1 reference

12 December 2020

Foundations of Cost-Effectiveness Analysis for Health and Medical Practices

1 reference

12 December 2020

Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens

1 reference

12 December 2020

French economic evaluations of influenza and influenza vaccination

1 reference

12 December 2020

Influenza vaccination of elderly persons. Reduction in pneumonia and influenza hospitalizations and deaths

1 reference

12 December 2020

The economic impact of pandemic influenza in the United States: priorities for intervention.

1 reference

12 December 2020

Economic impact of influenza. The individual's perspective

1 reference

12 December 2020

Standardizing methodologies for economic evaluation in health care. Practice, problems, and potential

1 reference

12 December 2020

Swine influenza vaccine and Guillain-Barré syndrome. Epidemic or artifact?

1 reference

12 December 2020

Economic evaluation of influenza vaccination. Assessment for The Netherlands

1 reference

12 December 2020

Cost-effectiveness of the influenza vaccine in a healthy, working-age population.

1 reference

12 December 2020

The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature.

1 reference

12 December 2020

The impact and cost of influenza in the elderly

1 reference

12 December 2020

10.2165/00002512-200017030-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1033637745

0 references

1 reference